Search by Drug Name or NDC
NDC 67386-0621-52 CARNEXIV 10 mg/mL Details
CARNEXIV 10 mg/mL
CARNEXIV is a INTRAVENOUS INJECTION, POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lundbeck Pharmaceuticals LLC. The primary component is CARBAMAZEPINE.
Product Information
| NDC | 67386-0621 |
|---|---|
| Product ID | 67386-621_001dfe05-5965-4d26-a432-aa35b8a3039d |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | CARNEXIV |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Carbamazepine |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | CARBAMAZEPINE |
| Labeler Name | Lundbeck Pharmaceuticals LLC |
| Pharmaceutical Class | Cytochrome P450 1A2 Inducers [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 2C19 Inducers [MoA], Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE], Mo |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA206030 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 67386-0621-52 (67386062152)
| NDC Package Code | 67386-621-52 |
|---|---|
| Billing NDC | 67386062152 |
| Package | 1 VIAL, GLASS in 1 CARTON (67386-621-52) / 20 mL in 1 VIAL, GLASS |
| Marketing Start Date | 2014-10-21 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |